TWO-YEAR CLINICAL RESPONSE TO BRODALUMAB, AN ANTI-IL-17 RECEPTOR ANTIBODY, IN PATIENTS WITH PSORIATIC ARTHRITIS

被引：2

作者：

Mease, P. ^{[1
,2
]}

Genovese, M. C. ^{[3
]}

Greenwald, M. W. ^{[4
]}

Ritchlin, C. T. ^{[5
]}

Beaulieu, A. ^{[6
]}

Deodhar, A. ^{[7
]}

Newmark, R. ^{[8
]}

Feng, J. ^{[8
]}

Erondu, N. ^{[8
]}

Nirula, A. ^{[8
]}

机构：

[1] Swedish Med Ctr, Seattle, WA USA

[2] Univ Washington, Seattle, WA 98195 USA

[3] Stanford Univ, Palo Alto, CA 94304 USA

[4] Desert Med Adv, Palm Desert, OH USA

[5] Univ Rochester, Med Ctr, Rochester, OH USA

[6] Univ Laval, Laval, PQ, Canada

[7] Oregon Hlth & Sci Univ, Portland, OR USA

[8] Amgen Inc, Thousand Oaks, CA USA

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷

关键词：

D O I：

10.1136/annrheumdis-2015-eular.3489

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

OP0175

引用

页码：136 / 137

页数：2

共 50 条

[1] Two-Year Clinical Response to Brodalumab, an Anti-Interleukin-17 Receptor Antibody, in Patients with Psoriatic Arthritis
Genovese, Mark C.
Mease, Philip J.
Greenwald, Maria
Ritchlin, Christopher T.
Beaulieu, Andre
Deodhar, Atul A.
Newmark, Richard
Feng, JingYuan
Erondu, Ngozi
Nirula, Ajay
ARTHRITIS & RHEUMATOLOGY, 2015, 67
[2] Clinical Response To Brodalumab, An Anti-Interleukin-17 Receptor Antibody, In Subjects With Psoriatic Arthritis
Genovese, Mark C.
Mease, Philip J.
Greenwald, Maria W.
Ritchlin, Christopher T.
Beaulieu, Andre
Deodhar, Atul
Newmark, Richard
Feng, JingYuan
Erondu, Ngozi
Nirula, Ajay
ARTHRITIS AND RHEUMATISM, 2013, 65 : S347 - S348
[3] FIFTY-TWO WEEK CLINICAL RESPONSE TO BRODALUMAB, AN ANTI-IL-17R ANTIBODY, IN SUBJECTS WITH PSORIATIC ARTHRITIS
Mease, P. J.
Genovese, M. C.
Greenwald, M. W.
Ritchlin, C. T.
Beaulieu, A.
Deodhar, A.
Newmark, R.
Feng, J.
Erondu, N.
Nirula, A.
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 740 - 741
[4] Clinical Response in Subjects with Psoriatic Arthritis Following One Year of Treatment with Brodalumab, an Anti-Interleukin-17 Receptor Antibody
Genovese, Mark C.
Mease, Philip
Greenwald, Maria W.
Ritchlin, Christopher T.
Beaulieu, A.
Deodhar, Atul A.
Newmark, Richard
Feng, JingYuan
Erondu, Ngozi
Nirula, Ajay
ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S687 - S687
[5] Brodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic Arthritis
Mease, Philip J.
Genovese, Mark C.
Greenwald, Maria W.
Ritchlin, Christopher T.
Beaulieu, Andre D.
Deodhar, Atul
Newmark, Richard
Feng, JingYuan
Erondu, Ngozi
Nirula, Ajay
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (24): : 2295 - 2306
[6] Gene Expression Profiles Normalized in Psoriatic Skin by Treatment with Brodalumab, a Human Anti-IL-17 Receptor Monoclonal Antibody
Russell, Chris B.
Rand, Hugh
Bigler, Jeannette
Kerkof, Keith
Timour, Martin
Bautista, Edgar
Krueger, James G.
Salinger, David H.
Welcher, Andrew A.
Martin, David A.
JOURNAL OF IMMUNOLOGY, 2014, 192 (08): : 3828 - 3836
[7] BRODALUMAB Anti-IL-17 Receptor Human Monoclonal Antibody Treatment of Psoriasis Treatment of Asthma
Gajdosik, Z.
DRUGS OF THE FUTURE, 2012, 37 (12) : 837 - 840
[8] EFFICACY OF BRODALUMAB, AN ANTI-IL-17R ANTIBODY, IN SUBJECTS WITH PSORIATIC ARTHRITIS
Mease, P. J.
Genovese, M. C.
Greenwald, M. W.
Ritchlin, C. T.
Beaulieu, A.
Newmark, R.
Feng, J.
Erondu, N.
Nirula, A.
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 85 - 85
[9] 52-WEEK RESPONSE TO BRODALUMAB, AN ANTI-IL-17R ANTIBODY, IN SUBJECTS WITH PSORIATIC ARTHRITIS
Mease, P. J.
Genovese, M. C.
Greenwald, M. W.
Ritchlin, C. T.
Beaulieu, A.
Deodhar, A.
Newmark, R.
Feng, J. Y.
Erondu, N.
Nirula, A.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (05) : 794 - 794
[10] Clinical response and improvement in psoriasis symptoms in subjects with psoriatic arthritis following treatment with brodalumab, an anti-IL-17R antibody
Mease, Philip
Nirula, Ajay
Ritchlin, Christopher
Greenwald, Maria
Genovese, Mark
Erondu, Ngozi
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : AB165 - AB165

← 1 2 3 4 5 →